Buy Abbott India; target of Rs 25,243: Sharekhan
Sharekhan is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 25,243 in its research report dated May 19, 2023.24-05-2023
24-05-2023
ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper cuttings of the Audited Financial Results of the Company for the quarter and year ended on March 31, 2023 published in Business Standard (All Editions) and Loksatta (Mumbai) on Saturday, May 20, 2023. This is for your information and record.20-05-2023
ABBOTT INDIA LTD. - 500488 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose disclosure of Related Party Transactions for the year ended March 31, 2023, in the format prescribed by SEBI under the Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021. The above disclosure is also available on the website of the Company at www.abbott.co.in. This is for your information and records.19-05-2023
ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Change in Management
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') and further to our letter dated March 17, 2023, we hereby inform you that upon recommendation of the Nomination and Remuneration and Audit Committees, the Board of Directors at its Meeting held today i.e. May 19, 2023 approved the appointment of Mr Sridhar Kadangode as Chief Financial Officer and Key Managerial Personnel of the Company effective July 1, 2023. The additional details required under the SEBI Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and Exchange Circular List/Comp/14/2018-19 dated June 20, 2018, are enclosed herewith as Annexure A. You are requested to take the same on record.19-05-2023
Abbott India recommends final dividend of 180 and special dividend of Rs. 145 per equity share for FY23
During today's closing session, Abbott India, a large-cap pharmaceutical company, had a market cap of 44,357.92 Cr.19-05-2023
ABBOTT INDIA LTD. - 500488 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24(A)(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose Secretarial Compliance Report for the year ended March 31, 2023, in the prescribed format, issued by Ms Neena Bhatia, Practicing Company Secretary (Membership No.: FCS 9492 and CP No.: 2661). This is for your information and records.19-05-2023
ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Change in Directorate
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we hereby inform you that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors at its Meeting held today i.e. May 19, 2023, approved the appointment of Mr Mahadeo Karnik (DIN: 02606595) as an Additional and Non-Executive Director on the Board of the Company effective July 1, 2023, to hold office upto the conclusion of the forthcoming Seventy-ninth Annual General Meeting of the Company. The additional details required under the SEBI Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and Exchange Circular List/Comp/14/2018-19 dated June 20, 2018, are enclosed herewith as Annexure A.19-05-2023
ABBOTT INDIA LTD. - 500488 - Annual General Meeting On August 9, 2023
We hereby inform you that Seventy-ninth Annual General Meeting of the Company is scheduled to be held on Wednesday, August 9, 2023. This is for your information and records.19-05-2023
ABBOTT INDIA LTD. - 500488 - Record Date For Determining Entitlement Of Members To Final And Special Dividends For The Financial Year Ended March 31, 2023.
Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company has fixed Friday, July 21, 2023 as the Record Date for determining entitlement of Members to Final and Special Dividends for the financial year ended March 31, 2023. The aforesaid Dividends, if approved by the shareholders at the forthcoming Seventy-ninth Annual General Meeting of the Company, will be paid on or after Wednesday, August 16, 2023. This is for your information and records.19-05-2023
ABBOTT INDIA LTD. - 500488 - Corporate Action-Board approves Dividend
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its Meeting held today i.e., May 19, 2023, recommended payment of final dividend of Rs. 180/- and special dividend of Rs. 145/- per equity share of Rs 10/- each for the year ended March 31, 2023, subject to approval of the Shareholders at the ensuing Seventy-ninth Annual General Meeting of the Company scheduled to be held on August 9, 2023. The aforesaid final and special dividends, if approved by the Members, will be paid on and after Wednesday, August 16, 2023 onwards.19-05-2023